Tracy Staton

Tracy Staton
Tracy Staton

Tracy Staton is the editor of FiercePharma and FiercePharmaMarketing. She has been a freelance writer for 8 years. Before that, she served as editor of the Dallas Business Journal, editor of Texas Business magazine, and a senior editor at American Way, the inflight magazine of American Airlines. She is based in Vermont and can be reached at [email protected], or find her on LinkedIn.

Stories by Tracy Staton

UPDATED: Pharma shares celebrate Trump win, but trade problems loom

Biopharma shares soared with Donald Trump's presidential victory as the threat of sweeping action against drug prices lifted. But Trump won't be idle on pricing, analysts say, and his ferocious opposition to trade deals could be a long-term headache for the decidedly global pharma business.
Justice Department building inscription

DOJ charges likely to hit only a few generics makers: Analysts

Generics makers lost $8.5 billion in value Thursday on news that the feds are prepping price-fixing charges against industry players. The good news: Though the danger is real--and quite significant--analysts figure it will be confined to only a few of the 12 companies that have received federal subpoenas.

Ex-Warner sales exec gets probation in prior auth HIPAA case

For pharma and a former Warner Chilcott manager, it could have been much worse. Ex-district manager Landon Eckles was sentenced to 1 year of probation and a fine of $10,000 for violating health privacy laws by filling out prior authorization forms for doctors who prescribed the Warner bone med Atelvia.

Forget price hikes pushing Enbrel growth, Amgen says

Amid all the brouhaha on drug prices there's this simple fact: Some drugs can still grow off price hikes. Others can't. Biogen, for instance, reaped most of its Tecfidera sales growth off price increases this year. Amgen says its blockbuster Enbrel's days of growing through price hikes are over.